Filing Flows › Wave Life Sciences (WVE) › Q3 2026 › vs Q2 2026
Wave Life Sciences (WVE) Q3 2026 vs Q2 2026 (quarter over quarter)
Wave Life Sciences's revenue rose $10.9M (+479%) from $2.3M in Q2 2026 to $13.2M in Q3 2026.
Wave Life Sciences, Q3 2026: revenue $13.2M (+73% year over year), operating margin -502.0%, net loss $61.9M, operating cash flow −$60.1M. The chart draws each line against Q2 2026, the increases inside each band.
Every line
| Line | Q3 2026 | Q2 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $13.2M | $2.3M | $10.9M | +479% |
| Other income, net | $4.1M | $4.4M | −$312K | -7% |
| Net loss | $61.9M | $69.4M | −$7.4M | -11% |
| Costs & expenses | $79.2M | $76.1M | $3.1M | +4% |
| Operating costs | $79.2M | $76.1M | $3.1M | +4% |
| Research & development | $53.8M | $51.3M | $2.5M | +5% |
| General & admin | $25.4M | $24.8M | $581K | +2% |
| Operating cash sources | $71.3M | $65.2M | $6.1M | +9% |
| Depreciation | $880K | $858K | $22K | +3% |
| Share-based compensation | $10.3M | $10.7M | −$445K | -4% |
| Cash used in operations | $60.1M | $53.6M | $6.6M | +12% |
| Net loss absorbed | $61.9M | $69.4M | −$7.4M | -11% |
| Working capital & other | $9.4M | −$4.2M | $13.6M | — |
Questions
How much did Wave Life Sciences's revenue grow quarter over quarter in Q3 2026?
Wave Life Sciences's revenue rose $10.9M (+479%) from $2.3M in Q2 2026 to $13.2M in Q3 2026.